/**/
RNS Number : 0720G
Collagen Solutions PLC
18 November 2015
 

Collagen Solutions Plc

(the "Company" or the "Group")

 

Appointment of Chief Business Officer

 

The Board of Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces the appointment of Jamal Rushdy as Chief Business Officer with immediate effect.

 

Mr Rushdy has over 20 years' experience in the medical device arena, specifically within two mid-size high growth public companies and three successful start-ups. He has a unique track record of building businesses with successful exits and transforming organisations through integration and performance improvement, adding value through business development and functional leadership.

 

Mr Rushdy has been employed at Tornier Inc, a Minneapolis extremities and biologics company, since 2007, most recently as Vice President of US Sales Operations.  During his tenure he also served as the Vice President of the company's Global Sports Medicine, Biologics, and Business Development group where he led multiple acquisitions and corporate partnerships, including several focused on biologic technologies. Previous roles include Vice President of Operations & Business Development at Nexa Orthopedics in San Diego where he led his division through a high-growth period driven by a significant expansion in the sales force and rapid product introductions leading to the successful acquisition of Nexa by Tornier.      

 

Mr Rushdy has a BSc in Mechanical Engineering from the University of California, San Diego and an MBA from the University of California Graduate School of Management in marketing and finance.

 

Commenting on the appointment, Stewart White, CEO of Collagen Solutions said: "Jamal will bring a wealth of sector specific business acumen and creativity to Collagen Solutions. His experience in the industry is second to none and we are delighted he will be joining us as at this exciting time in our growth and will be charged with growing our sales operations across the globe. We are at a key point in our growth where increased business development is critical and Jamal is well positioned to drive this forward. Our Chief Business Officer prior to this appointment, Geoff Bennett will continue as an Executive Director of Collagen Solutions plc and as Managing Director and CEO of our wholly-owned subsidiary Southern Lights Biomaterials, located in New Zealand.  Mr Bennett will also continue to lead our business development efforts in Asia."

 

 

 

Enquiries:

 

Collagen Solutions Plc


David Evans, Chairman

Tel: 07740 084 452

Stewart White, CEO

Tel: 0141 648 9100



Panmure Gordon


Robert Naylor (Corporate Finance)

Tel: 020 7886 2500





Walbrook PR Ltd

Tel: 020 7933 8780 or collagen@walbrookpr.com

Anna Dunphy

Mob: 07876 741 001

Mike Wort

Mob: 07900 608 002

 

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFFUFUWFISEEF
Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Jun 2024 to Jul 2024 Click Here for more Healthcare Inv Charts.
Healthcare Inv (LSE:HIO)
Historical Stock Chart
From Jul 2023 to Jul 2024 Click Here for more Healthcare Inv Charts.